Showing results for Indianapolis Campus
-
IU School of Medicine celebrates hundreds of new doctors, scientists at 2026 graduation
Indiana University School of Medicine graduated hundreds of new doctors and scientists at its annual commencement ceremony on May 15.
May 15, 2026 -
Chuckstrong raises more than $900,000 for IU cancer research
The 14th annual Chuckstrong Tailgate Gala raised more than $900,000 for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Apr 20, 2026 -
Renowned supportive oncology expert to lead IU center
Renowned supportive oncology expert Christian "Chris" Nelson will lead the Walther Center for Supportive Oncology.
Apr 01, 2026 -
IU School of Medicine celebrates Match Day 2026
Indiana School of Medicine graduates matched with residency programs across 37 states.
Mar 20, 2026 -
Cook Medical selects Indiana University as Interventional MRI Center of Excellence
Cook and IU are working to accelerate the advancement, validation and clinical integration of innovative MRI‑guided technologies.
-
IU researchers identify clotting protein as potential target in pancreatic cancer
Research published in Gastroenterology found a new possible way to slow pancreatic cancer spread.
Mar 10, 2026 -
Hidden blood mutations may be driving severe IBD — IU team uncovers new treatment target
IU researchers have linked an age-related blood condition to inflammatory bowel disease (IBD) and identified a potential treatment to reduce the severity of inflammation-driven diseases.
Mar 09, 2026 -
IU School of Medicine’s 2025 NIH funding ranked No. 15 among public universities
The National Institutes of Health invested more than $230 million in the Indiana University School of Medicine during federal fiscal year 2024-25.
Feb 26, 2026 -
Pediatrics researcher awarded funding to advance respiratory disease treatment
Indiana University researchers are driving innovation across fields and tackling real‑world problems through breakthrough discoveries.
-
IU researchers uncover targetable weakness in hard-to-treat blood cancer
IU School of Medicine researchers have found that acute myeloid leukemia relies on an inflammation signal that can be targeted to weaken the treatment-resistant blood ...
Jan 14, 2026